http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20080255-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9264830abb1546ae267a47cad928c5bd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 |
filingDate | 2008-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92c57ea4ea680252f530f37e30104243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e3108d6652001e24a3335fcb348389 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0205f0ff25ec2df068d49b2280d26b |
publicationDate | 2008-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | HR-P20080255-A2 |
titleOfInvention | USE OF CYCLETHANINE AND OTHER FUROPYRIDINS FOR THE TREATMENT OF PRINCIPLE SYSTOLIC HYPERTENSION, ISOLATED SYSTOLIC HYPERTENSION, INCREASED PULSE PRESSURE AND GENERAL HYPERTENSION |
abstract | The present invention provides mixtures of cycletanin and other furopyridines for the treatment of pulse hypertension, isolated systolic hypertension and general hypertension, in monotherapeutic forms (furopyridine only) and in mixtures combined with other antihypertensive agents, cardiovascular antidiabetic agents and / or oral agents. Such mixtures of furopyridine comprise enantiomerically pure (positive or negative) embodiments and non-racemic enantiomeric mixtures, and comprise daily doses of less than 50 mg. Further methods are provided for the treatment of general or systolic hypertension, wherein mixtures of furopyridine alone or in combination with another agent for the treatment of general hypertension or systolic hypertension, and related complications, are administered to patients. |
priorityDate | 2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.